糖衍生物的结构基础 碳酸无水酶IX的抑制
Janis Leitans1, Andris Kazaks1, Janis Bogans1
1Latvian Biomedical Research and Study Center, Ratsupites 1, 1067, Riga, Latvia.
ChemMedChem
|October 14, 2023
概括
研究人员研究了糖衍生物如何与人类的碳酸无水酶IX (hCA IX) 结合,这是一个癌症标. 这揭示了为更好的抗瘤药物设计选择性抑制剂的新方法.
科学领域:
- 生物化学 生化学
- 结构生物学 结构生物学
- 药用化学 医学化学
背景情况:
- 人类碳酸无水酶IX (hCA IX) 是抗瘤药物开发的验证标.
- 开发强效和选择性抑制剂对于有效的癌症治疗至关重要.
- 了解抑制剂结合机制是合理药物设计的关键.
研究的目的:
- 阐明糖衍生物与hCA IX的结合机制.
- 为设计强效和选择性hCA IX抑制剂提供结构性见解.
- 确定开发针对hCA IX的异型选择性抑制剂的策略.
主要方法:
- 对hCA IX-撒卡林衍生物复合物的晶体分析.
- 结构性研究对联体蛋白相互作用.
- 跨碳酸酶异型体的结合模式的比较分析.
主要成果:
- 撒卡林衍生物与hCA IX具有独特的结合方式,与硫胺化合物有相似之处,但具有不同的联体尾部方向.
- 确定了决定抑制剂结合和选择性的关键相互作用.
- 揭示了hCA IX和hCA II之间的异形特异性相互作用,突出显示了选择性抑制的潜力.
结论:
- 这项研究提供了对hCA IX抑制剂结合的全面结构洞察.
- 这些发现有助于合理设计新型,强效和选择性hCA IX抑制剂.
- 鉴定的异形特异性相互作用为针对hCA IX的向抗瘤疗法铺平了道路.
相关概念视频
The Physiology of Taste
3.9K
The perception of a salty flavor is facilitated by sodium ions within the oral salivary fluid. Upon consumption of a salty substance, salt crystals disassemble, leading to the liberation of its constituents—Na+ and Cl- ions. These ions subsequently dissolve into the salivary fluid present in the oral cavity. The external environment of the gustatory cells experiences an elevation in Na+ concentration, thereby establishing a potent concentration gradient. This gradient propels the...
3.9K
Amines to Sulfonamides: The Hinsberg Test
3.6K
The Hinsberg test is a method to identify primary, secondary and tertiary amines, named after its pioneer, Oscar Hinsberg. Here, amines are treated with benzenesulfonyl chloride, also known as the Hinsberg reagent, in the presence of an excess of aqueous base, followed by acidification. Based on the nature of the amines, different changes are observed.
Generally, a primary amine reacts with the Hinsberg reagent to produce an N-substituted benzenesulfonamide. The electron-withdrawing...
Generally, a primary amine reacts with the Hinsberg reagent to produce an N-substituted benzenesulfonamide. The electron-withdrawing...
3.6K
Indirect-Acting Cholinergic Agonists: Chemistry and Structure-Activity Relationship
589
Indirect-acting cholinergic agonists are agents that interact with the acetylcholinesterase enzyme in the synaptic cleft, preventing the breakdown of acetylcholine into choline and acetate. Consequently, the concentration of acetylcholine in the synaptic cleft increases. These agonists can be classified into reversible and irreversible inhibitors based on their duration of action.
Reversible inhibitors display short to medium durations of action. Short-acting agents include simple alcohols with...
Reversible inhibitors display short to medium durations of action. Short-acting agents include simple alcohols with...
589
Indirect-Acting Cholinergic Agonists: Mechanism of Action
1.9K
Indirect-acting cholinergic agonists work by interacting with an enzyme called acetylcholinesterase (AChE) in the synaptic cleft. They can be reversible or irreversible inhibitors and have different effects on the enzyme.
Reversible inhibitors like edrophonium bind to a specific part of the enzyme called the anionic catalytic site. They form noncovalent bonds, which means they are not strongly attached to the enzyme. This creates a temporary and less stable enzyme–inhibitor complex,...
Reversible inhibitors like edrophonium bind to a specific part of the enzyme called the anionic catalytic site. They form noncovalent bonds, which means they are not strongly attached to the enzyme. This creates a temporary and less stable enzyme–inhibitor complex,...
1.9K
Acidity and Basicity of Carboxylic Acid Derivatives
3.4K
Carboxylic acids are the strongest among organic acids, as they readily lose the hydroxyl proton to form a resonance-stabilized carboxylate ion. In comparison, the acid derivatives lack acidic hydrogens directly attached to a functional group. In these compounds, the acidic nature arises from their ability to lose α hydrogens, making them weakly acidic.
The relative acidic strength of the derivatives can be explained based on the extent of resonance stabilization of the conjugate base. The...
The relative acidic strength of the derivatives can be explained based on the extent of resonance stabilization of the conjugate base. The...
3.4K
Structure-Activity Relationships and Drug Design
737
Drug design is a dynamic field that involves discovering and developing new medications based on specific biological targets. This process heavily relies on structure-activity relationships (SAR) and quantitative structure-activity relationships (QSAR) to guide the design and optimization of efficient drugs.
SAR studies the intricate relationship between a drug's chemical structure and biological activity. It focuses on understanding how modifications to a drug's structure can influence...
SAR studies the intricate relationship between a drug's chemical structure and biological activity. It focuses on understanding how modifications to a drug's structure can influence...
737


